Suppliers / Styrax Pharma

Styrax Pharma

India reconciled across 3 public records · 2 entities Updated 9 July 2026

Styrax Pharma is an API manufacturer based in India. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 5 molecules. Customs aggregates show $543K of exports covering 17 molecules to 6 destinations in 2025.

4
active US DMFs
2
valid CEPs
3
registered plants 2 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Anakapalli, India 3018393466
Visakhapatnam, India Not on file
Anakapalli, India 3014406503

What they file, and where

Molecule Regulators Docs
Allopurinol EDQM 1
Dolutegravir US FDA 1
Itraconazole EDQM 1
Lamivudine US FDA 1
Tenofovir Disoproxil US FDA 1

Also appears on these molecule pages

Allopurinol API Dolutegravir API Itraconazole API Tenofovir Disoproxil API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $5K 1
2025 Not reported $543K 6
2024 Not reported $161K 6
2023 Not reported $827K 4

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Styrax Pharma

Does Styrax Pharma hold a US DMF or a CEP?
Styrax Pharma holds 4 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Styrax Pharma FDA-registered?
2 sites operated by Styrax Pharma carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Styrax Pharma manufacture?
3 registered sites are on record, in India (Anakapalli and Visakhapatnam among others). Every site is listed on this page with the register it came from.
What does Styrax Pharma make?
5 molecules are on record against Styrax Pharma, including Allopurinol, Dolutegravir, Itraconazole and Lamivudine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Styrax Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Matrix Pharmacorp shares 3 molecules Hetero shares 2 molecules Apitoria Pharma shares 1 molecule Cipla shares 1 molecule Alivus Life Sciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts